These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8826545)

  • 1. Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.
    Hayward P; Wardle J; Higgitt A; Gray J
    Psychopharmacology (Berl); 1996 Jun; 125(4):392-7. PubMed ID: 8826545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R; Beaudry P; Beauclair L; Chouinard G
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
    Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
    N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
    Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
    J Clin Psychopharmacol; 1997 Aug; 17(4):272-7. PubMed ID: 9241006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical scale to assess benzodiazepine withdrawal.
    Busto UE; Sykora K; Sellers EM
    J Clin Psychopharmacol; 1989 Dec; 9(6):412-6. PubMed ID: 2574193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment, discontinuation, and psychomotor effects of diazepam in women with generalized anxiety disorder.
    Pourmotabbed T; Mcleod DR; Hoehn-Saric R; Hipsley P; Greenblatt DJ
    J Clin Psychopharmacol; 1996 Jun; 16(3):202-7. PubMed ID: 8784650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
    Rickels K; Schweizer E; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.
    Romach MK; Kaplan HL; Busto UE; Somer G; Sellers EM
    J Clin Psychopharmacol; 1998 Apr; 18(2):121-31. PubMed ID: 9555597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD; Tremblay A; Gagnon A; Monpremier P; Berliss H; Oyewumi LK
    J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users.
    Mintzer MZ; Stoller KB; Griffiths RR
    Psychopharmacology (Berl); 1999 Nov; 147(2):200-9. PubMed ID: 10591888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence.
    Murphy SM; Tyrer P
    Br J Psychiatry; 1991 Apr; 158():511-6. PubMed ID: 1675901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketazolam and diazepam in anxiety: a controlled study.
    Rickels K; Csanalosi I; Greisman P; Mirman MJ; Morris RJ; Weise CC; Weiss G
    J Clin Pharmacol; 1980 Oct; 20(10):581-9. PubMed ID: 6108335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Farr I; Morton S
    Int Clin Psychopharmacol; 1993; 8(1):31-6. PubMed ID: 8097214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Psychopharmacology (Berl); 1983; 80(4):308-10. PubMed ID: 6137856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.